Clinical trialNCT07529756Not, yet, recruitingObservational

The ReCAna for Lower ExtremIty Venous OBstructions and In-StEnt Restenosis Registry

SponsorIntervene, Inc.Enrollment500Chronic Venous DiseaseChronic Venous Insufficiency, CVIEmbolism and ThrombosisThrombectomyThrombosis (Stent Thrombosis)Thrombosis, Venous+1 more conditions

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The goal of this observational study is to gather additional safety and performance (effectiveness) data on the device for the treatment of symptomatic lower extremity venous obstructions and occlusions. The main questions the study aims to answer are: * What is the observed rate of safety events through the 30-day follow-up? * What is the rate of technical success (acute procedural success) achieved at the index procedure? Participants already undergoing treatment with the Recana as part of their regular medical care will be followed for 1 year.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Kush R Desai, MD
Northwestern University
Principal Investigator
clinicaltrials.gov ↗
Sameh Sayfo, MD, MBA
Baylor Scott & White The Heart Hospital - Plano
Principal Investigator
clinicaltrials.gov ↗
William A Marston, MD
University of North Carolina
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Aug 2026
Primary completion: 31 Dec 2028
Completion: 31 Mar 2029
Last update posted: 3 Aug 2026
Registered enrollment: 500
Registry id: NCT07529756

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.